Industry News
Small Changes In The Genome Account For Gender Differences In Liver Cancer Risk
Jan 21, 2012
Men are four times more likely to develop liver cancer compared to women, a difference attributed to the sex hormones androgen and estrogen. Although this gender difference has been known for a long time, the molecular mechanisms by which estrogens prevent - and androgens promote - liver cancer remain unclear... Read More
Tumor Growth Not Halted By Cell Senescence
Jan 21, 2012
A collaboration between a cancer biologist from the University of Milano and 2 physicists has shown that cell senescence occurs spontaneously in melanoma cells, but does not stop their growth Since cancer cells grow indefinitely, it is commonly believed that senescence could act as a barrier against tumor growth and potentially be used as a way to treat cancer... Read More
Novel Gene Mutations Associated With Bile Duct Cancer Could Lead To Targeted Treatment
Jan 21, 2012
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited... Read More
Cholesterol-Lowering Statins May Treat Breast Cancer
Jan 21, 2012
Cholesterol-lowering statins seem to keep breast cancer at bay in some patients. Now researchers reporting in the January 20th issue of the journal Cell, a Cell Press publication, provide clues about how statins might yield those unexpected benefits. The findings also suggest that mutations in a single gene could be used to identify tumors likely to respond to statin therapy... Read More
New Drug Labels For Kidney Disease Patients
Jan 21, 2012
The U.S. Food and Drug Administration (FDA) recently recommended that clinicians be more conservative when they prescribe chronic kidney disease (CKD) patients with drugs that treat red blood cell deficiencies. But the drug label's recommendations fall short, according to two commentaries appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN)... Read More
Tumor Growth Not Halted By Cell Senescence
Jan 21, 2012
A collaboration between a cancer biologist from the University of Milano and 2 physicists has shown that cell senescence occurs spontaneously in melanoma cells, but does not stop their growth Since cancer cells grow indefinitely, it is commonly believed that senescence could act as a barrier against tumor growth and potentially be used as a way to treat cancer... Read More
Regorafenib Does Well In Metastatic Colorectal Trial
Jan 20, 2012
The latest results on Bayer HealthCare's investigational compound regorafenib (BAY 73-4506) from the international, multicenter, randomized, double-blind, placebo-controlled Phase III CORRECT (Colorectal cancer treated with regorafenib or place after failure of standard therapy) trial have been announced by Bayer HealthCare... Read More
Aspirin - Ability To Prevent Cervical Cancer In HIV Infected Women
Jan 20, 2012
According to a study published in the current issue of the journal Cancer Prevention Research, aspirin should be assessed for its ability to prevent cervical cancer developing in women infected with HIV. Aspirin has the potential to provide considerable benefit for women in Africa, the Caribbean and Latin America, regions where death rates from cervical cancer are extremely high... Read More
Aspirin - Ability To Prevent Cervical Cancer In HIV Infected Women
Jan 20, 2012
According to a study published in the current issue of the journal Cancer Prevention Research, aspirin should be assessed for its ability to prevent cervical cancer developing in women infected with HIV. Aspirin has the potential to provide considerable benefit for women in Africa, the Caribbean and Latin America, regions where death rates from cervical cancer are extremely high... Read More
Researchers Uncover Mechanism By Which Melanoma Drug Accelerates Secondary Skin Cancers
Jan 20, 2012
Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf®) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer... Read More
Previous Page Next Page